How the Viral Vector Bioanalytical Testing Services Market Is Supporting Advanced Therapies
Valued at USD 569.90 million in 2025, the global viral vector bioanalytical testing services market is projected to reach USD 649.07 million in 2026 and USD 1,877.41 million by 2034, growing at a CAGR of 14.2% during the forecast period 2026–2034. While AAV vectors and safety testing lead today, the fastest-growing segments point to efficacy validation, cell-based therapies, and digital...
0 Commentarios 0 Acciones 110 Views 0 Vista previa
AC Mingle https://acmingle.com